These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
676 related articles for article (PubMed ID: 11714042)
1. Frequency of isolation and antimicrobial resistance of gram-negative and gram-positive bacteria from patients in intensive care units of 25 European university hospitals participating in the European arm of the SENTRY Antimicrobial Surveillance Program 1997-1998. Fluit AC; Verhoef J; Schmitz FJ; Eur J Clin Microbiol Infect Dis; 2001 Sep; 20(9):617-25. PubMed ID: 11714042 [TBL] [Abstract][Full Text] [Related]
2. Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006. Zhanel GG; DeCorby M; Laing N; Weshnoweski B; Vashisht R; Tailor F; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; McCracken M; Mulvey MR; Johnson J; ; Hoban DJ Antimicrob Agents Chemother; 2008 Apr; 52(4):1430-7. PubMed ID: 18285482 [TBL] [Abstract][Full Text] [Related]
3. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Streit JM; Jones RN; Sader HS; Fritsche TR Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308 [TBL] [Abstract][Full Text] [Related]
4. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Jones RN; Sader HS; Fritsche TR; Pottumarthy S Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial. Zhang Z; Chen M; Yu Y; Pan S; Liu Y Antimicrob Resist Infect Control; 2018; 7():152. PubMed ID: 30564308 [TBL] [Abstract][Full Text] [Related]
6. Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000). Hoban DJ; Biedenbach DJ; Mutnick AH; Jones RN Diagn Microbiol Infect Dis; 2003 Apr; 45(4):279-85. PubMed ID: 12730000 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America). Mathai D; Jones RN; Pfaller MA; Diagn Microbiol Infect Dis; 2001 Jul; 40(3):129-36. PubMed ID: 11502382 [TBL] [Abstract][Full Text] [Related]
8. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016. Decousser JW; Woerther PL; Soussy CJ; Fines-Guyon M; Dowzicky MJ Antimicrob Resist Infect Control; 2018; 7():68. PubMed ID: 29876099 [TBL] [Abstract][Full Text] [Related]
9. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003). Sader HS; Fritsche TR; Jones RN Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569 [TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial. Vega S; Dowzicky MJ Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011. Kanj SS; Whitelaw A; Dowzicky MJ Int J Antimicrob Agents; 2014 Feb; 43(2):170-8. PubMed ID: 24315313 [TBL] [Abstract][Full Text] [Related]
12. Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients. Casellas JM; Tomé G; Bantar C; Bertolini P; Blázquez N; Borda N; Couto E; Cudmani N; Guerrera J; Juárez MJ; López T; Littvik A; Méndez E; Notario R; Ponce G; Quinteros M; Salamone F; Sparo M; Sutich E; Vaylet S; Wolff L Diagn Microbiol Infect Dis; 2003 Nov; 47(3):527-37. PubMed ID: 14596972 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial. Morfin-Otero R; Noriega ER; Dowzicky MJ Ann Clin Microbiol Antimicrob; 2015 Dec; 14():53. PubMed ID: 26667651 [TBL] [Abstract][Full Text] [Related]
14. Bacteriologic profile and antibiogram of blood culture isolates from a children's hospital in Kabul. Tariq TM J Coll Physicians Surg Pak; 2014 Jun; 24(6):396-399. PubMed ID: 24953929 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit. Sader HS; Jones RN; Dowzicky MJ; Fritsche TR Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565 [TBL] [Abstract][Full Text] [Related]
16. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection]. Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068 [TBL] [Abstract][Full Text] [Related]
17. Antimicrobial susceptibility of gram-negative and gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010. Balode A; Punda-Polić V; Dowzicky MJ Int J Antimicrob Agents; 2013 Jun; 41(6):527-35. PubMed ID: 23590898 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of 3931 organisms isolated from intensive care units in Canada: Canadian National Intensive Care Unit Study, 2005/2006. Zhanel GG; DeCorby M; Nichol KA; Wierzbowski A; Baudry PJ; Karlowsky JA; Lagacé-Wiens P; Walkty A; Mulvey MR; Hoban DJ; Diagn Microbiol Infect Dis; 2008 Sep; 62(1):67-80. PubMed ID: 18513913 [TBL] [Abstract][Full Text] [Related]
19. Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers. Sader HS; Jones RN; Andrade-Baiocchi S; Biedenbach DJ; Diagn Microbiol Infect Dis; 2002 Nov; 44(3):273-80. PubMed ID: 12493175 [TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007). Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]